Home Cart 0 Sign in  

[ CAS No. 6973-51-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 6973-51-9
Chemical Structure| 6973-51-9
Structure of 6973-51-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 6973-51-9 ]

Related Doc. of [ 6973-51-9 ]

Alternatived Products of [ 6973-51-9 ]

Product Details of [ 6973-51-9 ]

CAS No. :6973-51-9 MDL No. :MFCD00819610
Formula : C7H5N3O2S Boiling Point : -
Linear Structure Formula :- InChI Key :XPYJFCKUPMJFHE-UHFFFAOYSA-N
M.W : 195.20 Pubchem ID :238934
Synonyms :

Calculated chemistry of [ 6973-51-9 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 52.85
TPSA : 112.97 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.17 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.18
Log Po/w (XLOGP3) : 1.86
Log Po/w (WLOGP) : 1.79
Log Po/w (MLOGP) : 0.16
Log Po/w (SILICOS-IT) : 0.23
Consensus Log Po/w : 1.05

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.67
Solubility : 0.419 mg/ml ; 0.00215 mol/l
Class : Soluble
Log S (Ali) : -3.85
Solubility : 0.0273 mg/ml ; 0.00014 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.0
Solubility : 1.97 mg/ml ; 0.0101 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.52

Safety of [ 6973-51-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 6973-51-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 6973-51-9 ]
  • Downstream synthetic route of [ 6973-51-9 ]

[ 6973-51-9 ] Synthesis Path-Upstream   1~10

  • 1
  • [ 333-20-0 ]
  • [ 88-74-4 ]
  • [ 6973-51-9 ]
YieldReaction ConditionsOperation in experiment
86%
Stage #1: With nano-BF3/SiO2 In acetonitrile for 0.5 h; Cooling with ice
Stage #2: With bromine In acetonitrile at 0 - 20℃; for 5 h;
General procedure: A solution of substituted aniline (2 mmol) in acetonitrile (15 ml) was added to a solution of KSCN (8 mmol) in acetonitrile (15 ml). Then, 0.06 g (30 mol percent BF3) of nano-BF3/SiO2 was added to the mixture, then was placed in a freezing mixture of ice and salt and mechanically stirred for 30 min. Then, bromine (4 mmol, 0.2 ml) in acetonitrile (3 ml) as solvent was added from a dropping funnel at such a rate that the temperature never rose beyond 0°C. After all the bromine was added at 60 min, the solution was stirred for 4 h at room temperature. The progress of the reaction was monitored by TLC. Then, the mixture was poured into water with stirring and the mixture was heated to 70°C on a steam bath and filtered hot to remove the catalyst and the recovered catalyst was washed with acetone and reused in the reaction. The filtrate was neutralized with 10 percent NaOH solution and the precipitate was collected on a filter, dried and recrystallized from ethanol (10 ml) to afford the corresponding products. All of the 2-aminobenzothiazole products were identified by physical and spectroscopic data as reported below, compared and contrasted with authentic samples.#10;Spectral data for selected products#10;6-Bromo-1,3-benzothiazol-2-amine (2e) Yellow solid; Yield = 93 percent; m.p. =202–204°C; (m.p. = 203°C), FT-IR (KBr)/t(cm-1): 3315, 3012, 2835,1580, 1476, 1261, 920, 742, 512. 1H NMR (400 MHz, CDCl3)/d ppm: 5.44 (s, 2H, NH2) 7.4–7.5 (d, 2H, Ar–H), 7.71 (s, 1H, Ar–H); 13C NMR/(100 MHz, DMSO-d6)/d ppm: 119, 120.9, 125.15, 126.07, 133.1, 152.15, 167.75.#10;
Reference: [1] Synlett, 2012, vol. 23, # 15, p. 2219 - 2222
[2] Research on Chemical Intermediates, 2016, vol. 42, # 12, p. 7855 - 7868
  • 2
  • [ 1147550-11-5 ]
  • [ 88-74-4 ]
  • [ 6973-51-9 ]
YieldReaction ConditionsOperation in experiment
41%
Stage #1: at 10℃; for 0.5 h; Cooling with ice
Stage #2: at 0 - 20℃;
General procedure: GP2-1: In a flask were added by ammoniumthiocyanate (2.2 eq) and HOAc (5 volume), bromine (1.1 eq) in HOAc (5 volume)was added dropwise under ice-cooled condition, which was stirred at 10 0Cfor 30 min. After filtering off the solid, the filtrate was collected.In aseparate flask, aniline (1.0 eq) and HOAc (5 volume) were added. Then thefiltrate prepared above was added dropwise under 0 0C within 5 min.The mixture was kept stirring at rt overnight. After removal of solvent underreduced pressure, the residue was diluted with EA, neutralized with saturatedNa2CO3 solution, separated, passed through a pad ofCelite, and concentrated to dryness. The crude was purified by silica gelcolumn.GP2-2: To a round-bottomed flaskwas added 2-aminobenzothiazole (1.0eq) and CuCl2 (1.2 eq) in acetonitrile (10 volume), followed by slowaddition of tert-butyl nitrite (1.2eq). The gas evolved immediately. The reaction was greatly exothermic, and, ifnecessary, ice-water cooling was applied. The mixture was then stirred at rtfor hours, which was monitored by TLC. After completion, the reaction wasquenched by 1M HCl, washed by 1 M HCl twice and extracted by EA. The combinedorganic layer was washed by brine, dried over Na2SO4, concentrated and purifiedby flash column to give the product.
Reference: [1] Medicinal Chemistry Research, 2011, vol. 20, # 7, p. 1033 - 1041
[2] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 24, p. 7661 - 7670
[3] Journal of Enzyme Inhibition and Medicinal Chemistry, 2011, vol. 26, # 4, p. 527 - 534
  • 3
  • [ 51039-84-0 ]
  • [ 6973-51-9 ]
Reference: [1] Journal of the Chemical Society, 1927, p. 1190
[2] Helvetica Chimica Acta, 1940, vol. 23, p. 328,330
[3] Journal fuer Praktische Chemie (Leipzig), 1974, vol. 316, p. 154 - 158
[4] Acta Crystallographica Section C: Crystal Structure Communications, 1996, vol. 52, # 4, p. 1040 - 1042
  • 4
  • [ 2942-08-7 ]
  • [ 6973-51-9 ]
Reference: [1] J. Gen. Chem. USSR (Engl. Transl.), 1960, vol. 30, p. 1394 - 1397[2] Zhurnal Obshchei Khimii, 1960, vol. 30, p. 1363 - 1366
  • 5
  • [ 88-74-4 ]
  • [ 6973-51-9 ]
Reference: [1] Chemistry of Heterocyclic Compounds, 2009, vol. 45, # 11, p. 1343 - 1353
[2] European Journal of Medicinal Chemistry, 2010, vol. 45, # 9, p. 4293 - 4299
[3] Archiv der Pharmazie, 2010, vol. 343, # 11-12, p. 692 - 699
  • 6
  • [ 1280582-63-9 ]
  • [ 6973-51-9 ]
Reference: [1] Letters in Drug Design and Discovery, 2011, vol. 8, # 9, p. 717 - 724
[2] Letters in Drug Design and Discovery, 2011, vol. 8, # 8, p. 717 - 724
  • 7
  • [ 88-74-4 ]
  • [ 6973-51-9 ]
Reference: [1] Letters in Drug Design and Discovery, 2011, vol. 8, # 9, p. 717 - 724
[2] Letters in Drug Design and Discovery, 2011, vol. 8, # 8, p. 717 - 724
  • 8
  • [ 95-16-9 ]
  • [ 6973-51-9 ]
Reference: [1] J. Gen. Chem. USSR (Engl. Transl.), 1960, vol. 30, p. 1394 - 1397[2] Zhurnal Obshchei Khimii, 1960, vol. 30, p. 1363 - 1366
  • 9
  • [ 149-30-4 ]
  • [ 6973-51-9 ]
Reference: [1] J. Gen. Chem. USSR (Engl. Transl.), 1960, vol. 30, p. 1394 - 1397[2] Zhurnal Obshchei Khimii, 1960, vol. 30, p. 1363 - 1366
  • 10
  • [ 2719-30-4 ]
  • [ 6973-51-9 ]
Reference: [1] Acta Crystallographica Section C: Crystal Structure Communications, 1996, vol. 52, # 4, p. 1040 - 1042
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 6973-51-9 ]

Amines

Chemical Structure| 73458-39-6

[ 73458-39-6 ]

5-Nitrobenzo[d]thiazol-2-amine

Similarity: 0.94

Chemical Structure| 89793-81-7

[ 89793-81-7 ]

7-Nitrobenzo[d]thiazol-2-amine

Similarity: 0.90

Chemical Structure| 1477-42-5

[ 1477-42-5 ]

4-Methylbenzo[d]thiazol-2-amine

Similarity: 0.73

Chemical Structure| 14779-18-1

[ 14779-18-1 ]

7-Methylbenzo[d]thiazol-2-amine

Similarity: 0.73

Chemical Structure| 615-21-4

[ 615-21-4 ]

2-Hydrazinylbenzo[d]thiazole

Similarity: 0.73

Nitroes

Chemical Structure| 73458-39-6

[ 73458-39-6 ]

5-Nitrobenzo[d]thiazol-2-amine

Similarity: 0.94

Chemical Structure| 89793-81-7

[ 89793-81-7 ]

7-Nitrobenzo[d]thiazol-2-amine

Similarity: 0.90

Chemical Structure| 2942-06-5

[ 2942-06-5 ]

6-Nitrobenzothiazole

Similarity: 0.82

Chemical Structure| 2942-07-6

[ 2942-07-6 ]

5-Nitrobenzo[d]thiazole

Similarity: 0.82

Chemical Structure| 58759-63-0

[ 58759-63-0 ]

5-Nitrobenzothiazole-2-thiol

Similarity: 0.76